あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/12/01 | 2,055 | 2,060 | 2,030 | 2,030 | -25 | -1.2% | 28,000 |
| 2025/11/28 | 2,035 | 2,069 | 2,035 | 2,055 | +14 | +0.7% | 58,000 |
| 2025/11/27 | 2,064 | 2,066 | 2,033 | 2,041 | -23 | -1.1% | 43,300 |
| 2025/11/26 | 2,058 | 2,080 | 2,058 | 2,064 | +13 | +0.6% | 32,800 |
| 2025/11/25 | 2,081 | 2,081 | 2,049 | 2,051 | -13 | -0.6% | 28,700 |
| 2025/11/21 | 2,033 | 2,064 | 2,033 | 2,064 | +32 | +1.6% | 44,800 |
| 2025/11/20 | 2,049 | 2,050 | 2,028 | 2,032 | +9 | +0.4% | 42,000 |
| 2025/11/19 | 2,021 | 2,034 | 2,011 | 2,023 | +2 | +0.1% | 47,100 |
| 2025/11/18 | 2,027 | 2,038 | 2,021 | 2,021 | -12 | -0.6% | 41,300 |
| 2025/11/17 | 2,044 | 2,046 | 2,025 | 2,033 | -11 | -0.5% | 29,800 |
| 2025/11/14 | 2,050 | 2,060 | 2,040 | 2,044 | -2 | -0.1% | 34,000 |
| 2025/11/13 | 2,065 | 2,075 | 2,039 | 2,046 | +2 | +0.1% | 25,000 |
| 2025/11/12 | 2,050 | 2,068 | 2,035 | 2,044 | +11 | +0.5% | 45,400 |
| 2025/11/11 | 2,050 | 2,052 | 2,021 | 2,033 | -23 | -1.1% | 45,400 |
| 2025/11/10 | 2,059 | 2,059 | 2,034 | 2,056 | +14 | +0.7% | 30,600 |
| 2025/11/07 | 2,050 | 2,057 | 2,033 | 2,042 | ±0 | ±0% | 51,000 |
| 2025/11/06 | 2,007 | 2,047 | 1,990 | 2,042 | +65 | +3.3% | 176,400 |
| 2025/11/05 | 2,000 | 2,042 | 1,963 | 1,977 | -137 | -6.5% | 176,400 |
| 2025/11/04 | 2,099 | 2,126 | 2,078 | 2,114 | +20 | +1% | 72,200 |
| 2025/10/31 | 2,076 | 2,099 | 2,071 | 2,094 | +18 | +0.9% | 38,200 |
| 2025/10/30 | 2,111 | 2,111 | 2,064 | 2,076 | +15 | +0.7% | 210,900 |
| 2025/10/29 | 2,124 | 2,127 | 2,058 | 2,061 | -63 | -3% | 61,700 |
| 2025/10/28 | 2,178 | 2,178 | 2,120 | 2,124 | -64 | -2.9% | 75,500 |
| 2025/10/27 | 2,180 | 2,194 | 2,170 | 2,188 | +22 | +1% | 26,500 |
| 2025/10/24 | 2,204 | 2,204 | 2,157 | 2,166 | -19 | -0.9% | 36,800 |
| 2025/10/23 | 2,210 | 2,218 | 2,182 | 2,185 | -14 | -0.6% | 38,200 |
| 2025/10/22 | 2,206 | 2,212 | 2,188 | 2,199 | -10 | -0.5% | 39,000 |
| 2025/10/21 | 2,200 | 2,230 | 2,179 | 2,209 | +80 | +3.8% | 134,900 |
| 2025/10/20 | 2,154 | 2,174 | 2,112 | 2,129 | +14 | +0.7% | 110,300 |
| 2025/10/17 | 2,108 | 2,127 | 2,105 | 2,115 | +7 | +0.3% | 20,200 |
| 2025/10/16 | 2,117 | 2,135 | 2,108 | 2,108 | -9 | -0.4% | 25,900 |
| 2025/10/15 | 2,105 | 2,134 | 2,092 | 2,117 | +34 | +1.6% | 34,200 |
| 2025/10/14 | 2,102 | 2,125 | 2,065 | 2,083 | -62 | -2.9% | 58,800 |
| 2025/10/10 | 2,162 | 2,177 | 2,144 | 2,145 | -49 | -2.2% | 50,600 |
| 2025/10/09 | 2,196 | 2,198 | 2,177 | 2,194 | +3 | +0.1% | 32,400 |
| 2025/10/08 | 2,235 | 2,254 | 2,191 | 2,191 | -16 | -0.7% | 39,000 |
| 2025/10/07 | 2,215 | 2,224 | 2,190 | 2,207 | -12 | -0.5% | 54,700 |
| 2025/10/06 | 2,202 | 2,238 | 2,200 | 2,219 | +20 | +0.9% | 62,400 |
| 2025/10/03 | 2,188 | 2,217 | 2,188 | 2,199 | +11 | +0.5% | 38,000 |
| 2025/10/02 | 2,183 | 2,198 | 2,164 | 2,188 | +23 | +1.1% | 82,700 |
| 2025/10/01 | 2,201 | 2,246 | 2,149 | 2,165 | -123 | -5.4% | 186,000 |
| 2025/09/30 | 2,335 | 2,335 | 2,272 | 2,288 | -38 | -1.6% | 77,100 |
| 2025/09/29 | 2,352 | 2,380 | 2,320 | 2,326 | -43 | -1.8% | 51,000 |
| 2025/09/26 | 2,369 | 2,380 | 2,352 | 2,369 | -17 | -0.7% | 58,000 |
| 2025/09/25 | 2,393 | 2,395 | 2,368 | 2,386 | +11 | +0.5% | 41,100 |
| 2025/09/24 | 2,381 | 2,381 | 2,360 | 2,375 | -10 | -0.4% | 28,700 |
| 2025/09/22 | 2,375 | 2,403 | 2,360 | 2,385 | -1 | ±0% | 42,800 |
| 2025/09/19 | 2,400 | 2,418 | 2,379 | 2,386 | -3 | -0.1% | 63,100 |
| 2025/09/18 | 2,389 | 2,398 | 2,376 | 2,389 | +13 | +0.5% | 30,700 |
| 2025/09/17 | 2,410 | 2,425 | 2,371 | 2,376 | -13 | -0.5% | 59,000 |
1~
50
件表示中 / 1142件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかHD | 203,000円 | +10.7% | +17.5% | 2.71% | 11.53倍 | 0.86倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
| 栄研化 | 246,700円 | +4.1% | -3.1% | 2.35% | 21.57倍 | 1.85倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
| ネクセラファーマ | 84,700円 | +15.5% | - | 0.00% | - | 1.16倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| タウンズ | 52,700円 | +11.5% | -0.9% | 5.31% | 6.32倍 | 3.13倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| ヘリオス | 46,600円 | +78.6% | - | 0.00% | - | 42.87倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム